Enterovirus encephalitis is a rare but serious complication in people with multiple sclerosis on ocrelizumab, with hypogammaglobulinemia potentially increasing risk.
Highlights enterovirus encephalitis as a rare but serious complication in multiple sclerosis patients treated with ocrelizumab, emphasizing the need for clinician awareness and prompt testing.
Absolute Event Rate: 0% vs 0%
Enterovirus encephalitis is a rare but serious complication in pwMS receiving ocrelizumab; hypogammaglobulinemia may increase risk. Clinician awareness and prompt testing may improve outcomes.
Banks et al. (Tue,) reported a other. Enterovirus encephalitis is a rare but serious complication in people with multiple sclerosis on ocrelizumab, with hypogammaglobulinemia potentially increasing risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: